BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24265293)

  • 21. Notch1 Pathway Protects against Burn-Induced Myocardial Injury by Repressing Reactive Oxygen Species Production through JAK2/STAT3 Signaling.
    Cai W; Yang X; Han S; Guo H; Zheng Z; Wang H; Guan H; Jia Y; Gao J; Yang T; Zhu X; Hu D
    Oxid Med Cell Longev; 2016; 2016():5638943. PubMed ID: 27057278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolactin Signaling Stimulates Invasion via Na(+)/H(+) Exchanger NHE1 in T47D Human Breast Cancer Cells.
    Pedraz-Cuesta E; Fredsted J; Jensen HH; Bornebusch A; Nejsum LN; Kragelund BB; Pedersen SF
    Mol Endocrinol; 2016 Jul; 30(7):693-708. PubMed ID: 27176613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolactin-induced expression of cytokine-inducible SH2 signaling inhibitors in human hematopoietic progenitors.
    Cwikel S; Silvian-Drachsler I; Prolov L; Hooghe-Peters EL; Merchav S
    Exp Hematol; 2001 Aug; 29(8):937-42. PubMed ID: 11495699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin II induces angiogenic factors production partly via AT1/JAK2/STAT3/SOCS3 signaling pathway in MHCC97H cells.
    Ji Y; Wang Z; Li Z; Li K; Le X; Zhang T
    Cell Physiol Biochem; 2012; 29(5-6):863-74. PubMed ID: 22613986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localization and signaling of the prolactin receptor in the uterus of the common marmoset monkey.
    Dalrymple A; Jabbour HN
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1711-8. PubMed ID: 10770219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of cross-desensitization between leptin and prolactin signaling pathways despite the induction of suppressor of cytokine signaling 3 and PTP-1B.
    Roy AF; Benomar Y; Bailleux V; Vacher CM; Aubourg A; Gertler A; Djiane J; Taouis M
    J Endocrinol; 2007 Nov; 195(2):341-50. PubMed ID: 17951545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Janus kinase 2 (JAK2) regulates prolactin-mediated chloride transport in mouse mammary epithelial cells through tyrosine phosphorylation of Na+-K+-2Cl- cotransporter.
    Selvaraj NG; Omi E; Gibori G; Rao MC
    Mol Endocrinol; 2000 Dec; 14(12):2054-65. PubMed ID: 11117534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel antagonistic effect of the bone morphogenetic protein system on prolactin actions in regulating steroidogenesis by granulosa cells.
    Nakamura E; Otsuka F; Inagaki K; Miyoshi T; Yamanaka R; Tsukamoto N; Suzuki J; Ogura T; Makino H
    Endocrinology; 2010 Nov; 151(11):5506-18. PubMed ID: 20810564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PRL/PRLR Can Promote Insulin Resistance by Activating the JAK2/STAT5 Signaling Pathway.
    Wang PY; Jin CC; Liu C; Zhao ZJ; Yang HY
    Comput Math Methods Med; 2022; 2022():1456187. PubMed ID: 36238467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kurarinone targets JAK2-STAT3 signaling in colon cancer-stem-like cells.
    Prajapati KS; Kumar S
    Cell Biochem Funct; 2024 Mar; 42(2):e3959. PubMed ID: 38390770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a rat uterine cell line, U(III) cells: prolactin (PRL) expression and endogenous regulation of PRL-dependent genes; estrogen receptor beta, alpha(2)-macroglobulin, and decidual PRL involving the Jak2 and Stat5 pathway.
    Prigent-Tessier A; Barkai U; Tessier C; Cohen H; Gibori G
    Endocrinology; 2001 Mar; 142(3):1242-50. PubMed ID: 11181541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation of c-Src by prolactin is independent of Jak2.
    Fresno Vara JA; Carretero MV; Gerónimo H; Ballmer-Hofer K; Martín-Pérez J
    Biochem J; 2000 Jan; 345 Pt 1(Pt 1):17-24. PubMed ID: 10600634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-6 induces proliferation in adult spinal cord-derived neural progenitors via the JAK2/STAT3 pathway with EGF-induced MAPK phosphorylation.
    Kang MK; Kang SK
    Cell Prolif; 2008 Jun; 41(3):377-92. PubMed ID: 18485152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. α-Hederin inhibits interleukin 6-induced epithelial-to-mesenchymal transition associated with disruption of JAK2/STAT3 signaling in colon cancer cells.
    Sun D; Shen W; Zhang F; Fan H; Xu C; Li L; Tan J; Miao Y; Zhang H; Yang Y; Cheng H
    Biomed Pharmacother; 2018 May; 101():107-114. PubMed ID: 29477470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of JAK2/STAT3/vimentin signaling pathway on proliferation and migration of human colon cancer cells].
    Xu JH; Zhang C; Tang B; Hao YX; Chen J; Liu T; Cui H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Apr; 13(4):282-5. PubMed ID: 20422486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling.
    Pezet A; Favre H; Kelly PA; Edery M
    J Biol Chem; 1999 Aug; 274(35):24497-502. PubMed ID: 10455112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological targeting PTK6 inhibits the JAK2/STAT3 sustained stemness and reverses chemoresistance of colorectal cancer.
    Liu C; Pan Z; Chen Q; Chen Z; Liu W; Wu L; Jiang M; Lin W; Zhang Y; Lin W; Zhou R; Zhao L
    J Exp Clin Cancer Res; 2021 Sep; 40(1):297. PubMed ID: 34551797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethanol inhibits prolactin-induced activation of the JAK/STAT pathway in cultured astrocytes.
    DeVito WJ; Stone S
    J Cell Biochem; 1999 Aug; 74(2):278-91. PubMed ID: 10404396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
    Ibrahim SA; Gadalla R; El-Ghonaimy EA; Samir O; Mohamed HT; Hassan H; Greve B; El-Shinawi M; Mohamed MM; Götte M
    Mol Cancer; 2017 Mar; 16(1):57. PubMed ID: 28270211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex.
    Xu J; Zhang Y; Berry PA; Jiang J; Lobie PE; Langenheim JF; Chen WY; Frank SJ
    Mol Endocrinol; 2011 Apr; 25(4):597-610. PubMed ID: 21310852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.